Q4 Earnings Estimate for CME Group Issued By Zacks Research

CME Group Inc. (NASDAQ:CMEFree Report) – Equities researchers at Zacks Research boosted their Q4 2025 earnings estimates for shares of CME Group in a note issued to investors on Thursday, April 10th. Zacks Research analyst T. De now expects that the financial services provider will post earnings per share of $2.63 for the quarter, up from their previous forecast of $2.53. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s Q4 2026 earnings at $2.87 EPS.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%.

Other equities research analysts have also recently issued research reports about the company. Barclays upped their price objective on CME Group from $263.00 to $279.00 and gave the stock an “equal weight” rating in a research note on Monday, April 7th. Bank of America boosted their price objective on shares of CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research note on Wednesday, April 2nd. Oppenheimer raised their target price on shares of CME Group from $269.00 to $279.00 and gave the company an “outperform” rating in a research note on Friday, April 11th. Piper Sandler boosted their target price on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a report on Tuesday, April 8th. Finally, Morgan Stanley upgraded shares of CME Group from an “equal weight” rating to an “overweight” rating and set a $301.00 price target on the stock in a research note on Tuesday, April 8th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $247.47.

Get Our Latest Stock Analysis on CME Group

CME Group Trading Down 0.3 %

Shares of NASDAQ:CME opened at $262.87 on Monday. CME Group has a one year low of $190.70 and a one year high of $273.42. The stock has a market capitalization of $94.73 billion, a PE ratio of 27.18, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company’s 50-day moving average price is $256.03 and its two-hundred day moving average price is $239.72.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.90%. CME Group’s dividend payout ratio (DPR) is currently 51.71%.

Insider Buying and Selling

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. This trade represents a 12.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,076 shares of company stock worth $6,871,496. Corporate insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. SeaCrest Wealth Management LLC increased its holdings in CME Group by 3.0% during the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider’s stock worth $366,000 after purchasing an additional 40 shares during the period. New Age Alpha Advisors LLC grew its stake in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Avidian Wealth Enterprises LLC boosted its position in CME Group by 2.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock valued at $411,000 after buying an additional 45 shares during the last quarter. TFC Financial Management Inc. raised its position in CME Group by 8.4% during the 4th quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider’s stock worth $137,000 after buying an additional 46 shares during the last quarter. Finally, Waldron Private Wealth LLC raised its holdings in shares of CME Group by 2.0% during the fourth quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider’s stock worth $549,000 after purchasing an additional 47 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.